Adial Pharmaceuticals, Inc.
ADIL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001513525
In the last 90 days, Adial Pharmaceuticals, Inc. insiders filed 3 open-market purchases and 0 sales; 17 institutions reported holding it in 13F filings for Q2 2026, worth $334.6K in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Adial Pharmaceuticals, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- 0 vs. Q4 2022
- Shares held
- 2.51M
- +831.5K (+49.5%) vs. Q4 2022
- Total value
- $876.9K
- +$517.7K (+144.1%) vs. Q4 2022
- New holders
- 2
- 6 more added
- Sold out
- 2
- 6 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ADIL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 17 | $334.6K |
| Q1 2026 | 15 | $63.8K |
| Q4 2025 | 24 | $778.4K |
| Q3 2025 | 17 | $214.8K |
| Q2 2025 | 17 | $70.8K |
| Q1 2025 | 14 | $152.7K |
| Q4 2024 | 15 | $298.1K |
| Q3 2024 | 12 | $195.9K |
| Q2 2024 | 16 | $328.0K |
| Q1 2024 | 16 | $236.2K |
| Q4 2023 | 17 | $495.3K |
| Q3 2023 | 11 | $164.2K |
| Q2 2023 | 21 | $488.2K |
| Q1 2023 | 23 | $876.9K |
| Q4 2022 | 23 | $359.2K |
| Q3 2022 | 28 | $692.1K |
| Q2 2022 | 26 | $2.27M |
| Q1 2022 | 23 | $6.38M |
| Q4 2021 | 24 | $3.61M |
| Q3 2021 | 21 | $5.50M |
| Q2 2021 | 19 | $3.15M |
| Q1 2021 | 20 | $1.95M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Adial Pharmaceuticals, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Benjamin F. Edwards & Company, Inc. | 1,000 | $0 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 2,748 | $0 | 0.00% | +2,706+6,442.9% | Added |
| Morgan Stanley | 535 | $187 | 0.00% | −42−7.3% | Reduced |
| Wells Fargo & Company | 919 | $322 | 0.00% | +3+0.3% | Added |
| UBS Group AG | 10,630 | $3.72K | 0.00% | −11,425−51.8% | Reduced |
| Envestnet Asset Management Inc | 13,088 | $4.58K | 0.00% | +13,088 | New |
| Two Sigma Investments, LP | 17,707 | $6.20K | 0.00% | −40,682−69.7% | Reduced |
| Advisor Group Holdings, Inc. | 23,346 | $8.09K | 0.00% | +15,025+180.6% | Added |
| Empirical Financial Services, LLC d.b.a. Empirical Wealth Management | 25,000 | $8.75K | 0.00% | 00.0% | Unchanged |
| Brown Advisory Inc | 26,040 | $9.11K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 29,705 | $10.4K | 0.00% | 00.0% | Unchanged |
| Truist Financial Corp | 33,862 | $11.9K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 36,461 | $12.0K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 45,994 | $16.0K | 0.00% | −41,411−47.4% | Reduced |
| Two Sigma Securities, LLC | 48,748 | $17.1K | 0.00% | +17,365+55.3% | Added |
| Raffa Wealth Management, LLC | 52,334 | $18.3K | 0.01% | 00.0% | Unchanged |
| State Street Corp | 52,354 | $18.3K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 100,900 | $35.0K | 0.00% | −150,986−59.9% | Reduced |
| Geode Capital Management, LLC | 137,464 | $48.1K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 203,358 | $71.2K | 0.00% | −275,517−57.5% | Reduced |
| Susquehanna International Group, LLP | 222,283 | $77.8K | 0.00% | +131,287+144.3% | Added |
| BlackRock Inc. | 225,855 | $79.0K | 0.00% | +1,134+0.5% | Added |
| Manchester Capital Management LLC | 1,202,452 | $420.9K | 0.06% | +1,202,452 | New |
| HRT Financial LP | 0 | $0 | 0.00% | −31,291−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −200−100.0% | Sold out |